Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Lung Neoplasms 102Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 16Neoplasm Metastasis 14Melanoma 14Brain Neoplasms 14Small Cell Lung Carcinoma 13Esophageal Neoplasms 10Colorectal Neoplasms 9Carcinoma, Renal Cell 9Pancreatic Neoplasms 8Ovarian Neoplasms 8Adenocarcinoma of Lung 8Prostatic Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 6Stomach Neoplasms 5Carcinoma, Transitional Cell 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Sarcoma, Kaposi 4Rectal Neoplasms 4Meningeal Carcinomatosis 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3HIV Infections 3Carcinoma, Medullary 3

Interventions

Spinal Puncture 2sapanisertib 1Specimen Handling 1Phlebotomy 1Nivolumab 1Magnetic Resonance Spectroscopy 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Neoplasms × Magnetic Resonance Spectroscopy × Thoracic × Clear all
NCT03025256 2026-05-05

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Recruiting
75 enrolled
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡